Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Product news roundup from Datamonitor

May 9, 2007 Research and Development, Sales and Marketing

Additional indication for Pfizer's FragminThe FDA has approved a new indication for blood clot drug Fragmin to treat symptomatic venous …
News

News update from Datamonitor

May 1, 2007 Research and Development, Sales and Marketing

Common pain medications do not prevent Alzheimer's diseaseOver-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's …
News

Pharma news from Datamonitor

April 26, 2007 Research and Development, Sales and Marketing

Gemin X compound effective in leukemiaGemin X has said its compound that treats acute lymphoblastic leukemia produced positive results in …
News

Product update from Datamonitor

April 26, 2007 Research and Development, Sales and Marketing

Schering-Plough receives Japanese approval for ZetiaSchering-Plough has received Japanese marketing approval for Zetia, a cholesterol-lowering agent that inhibits the absorption …
News

UK science at a ‘tipping point’

April 26, 2007 Research and Development

The future for the UK's medical science base looks very bright, according to leading figures in the government, science and …
News

Clinical trial news from Datamonitor

April 18, 2007 Research and Development

Array BioPharma receives payment for cancer inhibitorArray BioPharma has received a $2 million milestone payment from AstraZeneca after its MEK …
News

Europe’s buoyant biotech set for further growth

April 16, 2007 Research and Development, Sales and Marketing biotech

A new comprehensive survey of the world's biotechnology industry shows the sector to be in great health, with indications of …
News

NICE in the dock: what the judicial review means for pharma

April 16, 2007 Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review

The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …
Feature

Product news from Datamonitor

April 16, 2007 Research and Development, Sales and Marketing

Carrington Laboratories to manufacture sublingual vaccinesCarrington Laboratories has reported that its subsidiary DelSite Biotechnologies has entered into an agreement with …
News

Product Development Update

April 12, 2007 Research and Development, Sales and Marketing

Product news round-up from Datamonitor ChemGenex begins CML trialChemGenex Pharmaceutical has treated the first patient in a new phase II/III clinical …
News

Pfizer’s torcetrapib results cast doubt on CETP inhibitors

March 30, 2007 Research and Development, Sales and Marketing Pfizer, lipid

New data on Pfizer's ill-fated torcetrapib suggest the drug doesn't reduce arterial plaque, casting doubt on other drugs in the …
News

Post-Northwick Park European guidelines out for consultation

March 26, 2007 Research and Development phase I

European regulators have produced draft guidance for phase I research, designed to minimise the risk of a repeat of the …
News

HIV market: collaborative combinations

March 26, 2007 Research and Development, Sales and Marketing HIV, drug development, marketing

Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …
Feature

AstraZeneca’s pipeline suffers another blow

March 23, 2007 Research and Development

AstraZeneca seems likely to abandon another of its drug projects in what is the latest major late-stage failure to have …
News

BMS expands Indian biotech collaboration

March 21, 2007 Research and Development BMS, India

Bristol-Myers Squibb will establish a new integrated drug development facility in Bangalore as part of an expansion of its R&D …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025